By Josh White
Date: Wednesday 15 Oct 2025
(Sharecast News) - Ixico announced two new agreements worth a combined £1.2m on Wednesday, including a contract to support the validation of a diagnostic blood test and an extension to an existing Alzheimer's disease clinical trial.
By Josh White
Date: Tuesday 12 Aug 2025
(Sharecast News) - Ixico has secured two new clinical trial contracts in neurological disorders with a combined value of about £1.3m, it announced on Friday, extending its presence in both Alzheimer's disease and rare central nervous system conditions.
By Josh White
Date: Thursday 17 Jul 2025
(Sharecast News) - Ixico said in an update on Thursday that it expects revenue for the financial year ending 30 September to be at least £6.3m, ahead of market expectations and representing a 9% increase from the prior year.
Currency | UK Pounds |
Share Price | 12.25p |
Change Today | -0.25p |
% Change | -2.00 % |
52 Week High | 14.00p |
52 Week Low | 7.75p |
Volume | 212,179 |
Shares Issued | 92.67m |
Market Cap | £11.35m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:06 | 1,921 @ 12.39p |
16:02 | 216 @ 12.49p |
11:04 | 614 @ 12.50p |
11:04 | 8 @ 12.50p |
11:04 | 5,616 @ 12.16p |
You are here: research